🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/09/2015 5,79 5,94 5,29 5,76 +0,17% 11,24% 3.547.600
29/09/2015 6,40 6,56 5,68 5,75 -8,73% 13,75% 2.555.400
28/09/2015 7,27 7,39 6,23 6,30 -13,22% 15,96% 3.111.900
25/09/2015 7,60 7,92 7,00 7,26 +0,97% 12,11% 5.667.700
24/09/2015 9,01 9,36 7,06 7,19 +6,68% 25,53% 22.498.100
23/09/2015 7,25 7,33 6,68 6,74 -4,40% 8,90% 2.050.700
22/09/2015 7,61 7,61 6,87 7,05 -4,86% 9,72% 2.214.000
21/09/2015 7,58 7,72 7,13 7,41 +0,95% 7,78% 2.520.200
18/09/2015 7,42 7,77 7,10 7,34 -1,74% 9,03% 1.902.800
17/09/2015 7,66 7,69 7,28 7,47 -1,97% 5,35% 2.447.300
16/09/2015 7,06 7,84 7,02 7,62 +8,86% 11,61% 2.911.700
15/09/2015 6,63 7,09 6,49 7,00 +7,03% 9,05% 1.878.500
14/09/2015 6,31 6,61 6,16 6,54 +2,19% 7,16% 1.283.300
11/09/2015 6,00 6,60 6,00 6,40 +11,89% 10,00% 3.845.900
10/09/2015 5,55 5,77 5,54 5,72 +3,06% 4,14% 1.137.800
09/09/2015 5,56 5,68 5,49 5,55 +1,28% 3,49% 1.145.800
08/09/2015 5,61 5,65 5,41 5,48 -0,72% 4,28% 1.042.600
04/09/2015 5,37 5,56 5,24 5,52 +0,73% 5,96% 970.300
03/09/2015 5,81 5,85 5,38 5,48 -6,00% 8,09% 1.102.300
02/09/2015 5,88 5,88 5,53 5,83 +3,00% 5,95% 1.147.800
01/09/2015 5,79 5,92 5,61 5,66 -4,55% 5,35% 705.900
31/08/2015 5,69 6,06 5,63 5,93 +2,77% 7,49% 961.700
28/08/2015 5,64 5,79 5,61 5,77 +1,76% 3,19% 711.200
27/08/2015 5,63 5,74 5,48 5,67 +2,53% 4,62% 946.600
26/08/2015 5,32 5,53 5,21 5,53 +7,17% 6,02% 1.042.100
25/08/2015 5,18 5,43 5,09 5,16 +2,99% 6,56% 997.600
24/08/2015 4,90 5,34 4,35 5,01 -10,05% 20,20% 2.185.500
21/08/2015 5,40 5,74 5,30 5,57 +0,36% 8,15% 1.167.800
20/08/2015 5,48 5,66 5,45 5,55 +0,00% 3,83% 1.032.000
19/08/2015 5,69 5,96 5,46 5,55 -3,48% 8,86% 936.700